Tempus AI Expands Into Digital Pathology With Paige Acquisition

Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Friday after acquiring Paige, an AI company specializing in digital pathology. Tempus is a technology company focused on adopting AI to advance precision medicine. The acquisition allows Tempus to grow its dataset, expand its experienced technical team, and establish a strong footprint in digital pathology. Also Read: Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins Deal consideration of $81.25 million is